Activation of src/kinase/phospholipase c/mitogenactivated protein kinase and induction of neurite expression by ATP, independent of nerve growth factor

Neuroscience

Volumn 141, Issue 1, 2006, Pages 179-189

  Lakshmi, S ^a   Joshi, P G ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

ATP; MAP kinase; Neurite outgrowth; Neuro2a cells; P2Y receptor

Indexed keywords

1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADENOSINE; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE 5'-O-(3-THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATE; DRUG DERIVATIVE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; NITRILE; PHOSPHOLIPASE C; PROTEIN TYROSINE KINASE; PURINE P2 RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y2 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID; SURAMIN;

ANIMAL; ARTICLE; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MOUSE; NEURITE; NEUROBLASTOMA; TUMOR CELL LINE;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; BUTADIENES; CELL LINE, TUMOR; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, CONFOCAL; MITOGEN-ACTIVATED PROTEIN KINASES; NEURITES; NEUROBLASTOMA; NITRILES; PHOSPHOLIPASE C; PYRIDOXAL PHOSPHATE; RECEPTORS, PURINERGIC P2; SRC-FAMILY KINASES; SURAMIN;

EID: 33749068708     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.03.074     Document Type: Article

References (42)

1. Abbracchio Cattabeni F, Clementi F, SherE(1989) Adenosine receptors linked to adenylate cyclase activity in human neuroblastoma cells: modulation during cell differentiation. Neuroscience 30:819-825.
2. Behrsing HP, Vulliet PR (2004) Mitogen-activated protein kinase mediates purinergic-enhanced nerve growth factor-induced neurite outgrowth in PC12 cells. J Neurosci Res 78:64-74.
3. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999) Cell survival promoted by the Ras-MAPK signaling pathways by the transcription dependent and -independent mechanisms. Science 286:1358-1362.
4. Brambilla R, Abbracchio MP (2001) Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann N Y Acad Sci 939:54-62.
5. Bryan BA, Cai Y, Liu M (2006) The Rho-family guanine nucleotide exchange factor GEFT enhances retinoic acid-and cAMP-induced neurite outgrowth. J Neurosci Res 83:1151-1159.
6. Canossa M, Gartner A, Campana G, Inagaki N, Thoenen H (2001) Regulated secretion of neurotrophins by metabotropic glutamate group I (mGluRI) and Trk receptor activation is mediated via phospholipase C signaling pathways. EMBO J 20:1640-1650.
7. Carpenter G, Ji Q (1999) Phospholipase C-gamma as a signal-transducing element. Exp Cell Res 253:15-24.
8. Charlton SJ, Brown CA, Weisman GA, Turner JT, Erb L, Boarder MR (1996) PPADS and suramin as antagonists at cloned P2Y-and P2U-purinoceptors. Br J Pharmacol 118:704-710.
9. Chen CC, Chen WC (1997) P2Y receptor linked to phospholipase C: stimulation of neuro2a cells by UTP and ATP and possible regulation by protein kinase C subtype epsilon. J Neurochem 69:1409-1416.
10. BC, Chen Lin WW (1997) Inhibition of ecto-ATPase by the P2 purinoceptor agonists, ATPgammaS, alpha, beta-methylene-ATP, and AMP-PNP, in endothelial cells. Biochem Biophys Res Commun 233:442-446.
11. Chorna NE, Santiago-Perez LI, Erb L, Seye CI, Neary JT, Sun GY, Weisman GA, Gonzalez FA (2004) P2Y receptors activate neuroprotective mechanisms in astrocytic cells. J Neurochem 91:119-132.
12. Communi D, Robaye B, Boeynaems JM (1999) Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol 128:1199-1206.
13. D'Ambrosi N, Cavaliere F, Merlo D, Milazzo L, Mercanti D, Volonte C (2000) Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells. Neuropharmacology 39:1083-1094.
14. Evangelopoulos ME, Weis J, Kruttgen A (2005) Signaling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR. Oncogene 24:3309-3318.
15. Fang Y, Wu G, Xie X, Lu ZH, Ledeen RW (2000) Endogenous GM1 ganglioside of the plasma membrane promotes neuritogenesis by two mechanisms. Neurochem Res 25:931-940.
16. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradely DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
17. Franke H, Illes P (2006) Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther 109:297-324.
18. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
19. Gutkind JS (1998) The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273:1839-1842.
20. Gysbers JW, Guarnieri S, Mariggio MA, Pietrangelo T, Fano G, Rathbone MP (2000) Extracellular guanosine 5= triphosphate enhances nerve growth factor-induced neurite outgrowth via increases in intracellular calcium. Neuroscience 96:817-824.
21. Haendeler J, Yin G, Hojo Y, Saito Y, Melaragno M, Yan C, Sharma VK, Heller M, Aebersold R, Berk BC (2003) GIT1 mediates Src-dependent activation of phospholipase C gamma by angiotensin II and epidermal growth factor. J Biol Chem 278:49936-49944.
22. Hur EM, Park YS, Lee BD, Jang IH, Kim HS, Kim TD, Suh PG, Ryu SH, Kim KT (2004) Sensitization of epidermal growth factor-induced signaling by bradykinin is mediated by c-Src. Implications for a role of lipid microdomains. J Biol Chem 279:5852-5860.
23. Kaulich M, Qurishi R, Muller CE (2003) Extracellular metabolism of nucleotides in neuroblastoma x glioma NG108-15 cells determined by capillary electrophoresis. Cell Mol Neurobiol 23:349-364.
24. Lad SP, Neet KE, Mufson EJ (2003) Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr Drug Target CNS Neurol Disord 2:215-234.
25. Lakshmi S, Joshi PG (2005) Co-activation of P2Y2 receptor and TRPV channel by ATP: Implications for ATP induced pain. Cell Mol Neurobiol 25:819-832.
26. Lambrecht G (2000) Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol 362:340-350.
27. Liu J, Liao Z, Camden J, Griffin KD, Garrad RC, Santiago-Perez LI, Gonzalez FA, Seye CI, Weisman GA, Erb L (2004) Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J Biol Chem 279:8212-8218.
28. Matta SG, Yorke G, Roisen FJ (1986) Neuritogenic and metabolic effects of individual gangliosides and their interaction with nerve growth factor in cultures of neuroblastoma and pheochromocytoma. Brain Res 392:243-252.
29. Nakanishi O, Shibasaki F, Hidaka M, Homma Y, Takenawa T (1993) Phospholipase C-gamma 1 associates with viral and cellular Src kinases. J Biol Chem 268:10754-10759.
30. Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells Trends. Neurosci 19:13-18.
31. Neary JT, McCarthy M, Cornell-Bell A, Kang Y (1999) Trophic signaling pathways activated by purinergic receptors in rat and human astroglia. Prog Brain Res 120:323-332.
32. Neary JT (2000) Trophic actions of extracellular ATP: gene expression profiling by DNA array analysis. J Auton Nerv Syst 81:200-204.
33. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067.
34. Prinetti A, Iwabuchi K, Hakomori S (1999) Glycosphingolipid-enriched signaling domain in mouse neuroblastoma neuro2a cells. Mechanism of ganglioside-dependent neuritogenesis. J Biol Chem 274: 20916-20924.
35. Puceat M, Vassort G (1996) Purinergic stimulation of rat cardiomyocytes induces tyrosine phosphorylation and membrane association of phospholipase C gamma: a major mechanism for InsP3 generation. Biochem J 318:723-728.
36. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
37. Rathbone MP, Middlemiss PJ, Gysbers JW, DeForge S, Costello P, Del Maestro RF (1992) Purine nucleosides and nucleotides stimulate proliferation of a wide range of cell types. In Vitro Cell Dev Biol 28A:529-536.
38. Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MA, Reed JK, Ciccarelli R, Di Iorio P, Caciagli F (1999) Trophic effects of purines in neurons and glial cells. Prog Neurobiol 59:663-690.
39. Ravichandra B, Joshi PG (1999) Regulation of transmembrane signaling by ganglioside GM1: interaction of anti-GM1 with neuro2a cells. J Neurochem 73:557-567.
40. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286:2358-2361.
41. Soltoff SP (1998) Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2]i elevation can substitute for receptor activation. J Biol Chem 273:23110-23117.
42. Swanson KD, Reigh C, Landreth GE (1998) ATP-stimulated activation of the mitogen-activated protein kinases through ionotropic P2X2 purinoreceptors in PC12 cells. Difference in purinoreceptor sensitivity in two PC12 cell lines. J Biol Chem 273:19965-19971.